[go: up one dir, main page]

AU2002212863A1 - Stable pharmaceutical form of an anticancer drug - Google Patents

Stable pharmaceutical form of an anticancer drug

Info

Publication number
AU2002212863A1
AU2002212863A1 AU2002212863A AU1286302A AU2002212863A1 AU 2002212863 A1 AU2002212863 A1 AU 2002212863A1 AU 2002212863 A AU2002212863 A AU 2002212863A AU 1286302 A AU1286302 A AU 1286302A AU 2002212863 A1 AU2002212863 A1 AU 2002212863A1
Authority
AU
Australia
Prior art keywords
anticancer drug
pharmaceutical form
stable pharmaceutical
stable
anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212863A
Inventor
Iwona Czarnecka
Stanislaw Janicki
Wladyslaw Karas
Zdzislaw Mroczek
Malgorzata Sznitowska
Andrzej Tyrala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instytut Biochemii I Biofizyki of PAN
Akademia Medyczna
Warszawskie Zaklady Farmaceutyczne Polfa SA
Original Assignee
INST CHEMII ORGANICZNEJ PAN
Instytut Biochemii I Biofizyki of PAN
Akademia Medyczna
Warszawskie Zaklady Farmaceutyczne Polfa SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST CHEMII ORGANICZNEJ PAN, Instytut Biochemii I Biofizyki of PAN, Akademia Medyczna, Warszawskie Zaklady Farmaceutyczne Polfa SA filed Critical INST CHEMII ORGANICZNEJ PAN
Publication of AU2002212863A1 publication Critical patent/AU2002212863A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002212863A 2000-10-31 2001-10-19 Stable pharmaceutical form of an anticancer drug Abandoned AU2002212863A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL343615A PL203300B1 (en) 2000-10-31 2000-10-31 Stable pharmacological form of anticarcinogenic drug and method of obtaining such drug in that form
PL343615 2000-10-31
PCT/PL2001/000082 WO2002036582A1 (en) 2000-10-31 2001-10-19 Stable pharmaceutical form of an anticancer drug

Publications (1)

Publication Number Publication Date
AU2002212863A1 true AU2002212863A1 (en) 2002-05-15

Family

ID=20077651

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212863A Abandoned AU2002212863A1 (en) 2000-10-31 2001-10-19 Stable pharmaceutical form of an anticancer drug

Country Status (14)

Country Link
EP (1) EP1363892B1 (en)
AU (1) AU2002212863A1 (en)
BG (1) BG65985B1 (en)
CZ (1) CZ300836B6 (en)
DE (1) DE60122384T2 (en)
HU (1) HUP0303089A3 (en)
LT (1) LT5069B (en)
PL (1) PL203300B1 (en)
RU (1) RU2236227C1 (en)
SI (1) SI21138B (en)
SK (1) SK287850B6 (en)
UA (1) UA75620C2 (en)
WO (1) WO2002036582A1 (en)
ZA (1) ZA200303276B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0600533A2 (en) * 2001-11-30 2006-11-28 Bristol Myers Squibb Co Paclitaxel solvates
EP1947094A3 (en) 2003-12-12 2009-02-18 Quiral Quimica Do Brasil Process for the preparation of taxane derivatives
AR054215A1 (en) * 2006-01-20 2007-06-13 Eriochem Sa A PHARMACEUTICAL FORMULATION OF A TAXANE, A SOLID COMPOSITION OF A LIOFILIZED TAXAN FROM AN ACETIC ACID SOLUTION, A PROCEDURE FOR THE PREPARATION OF A SOLID COMPOSITION OF A TAXANE, A SOLUBILIZING COMPOSITION OF A LIOFILIZED TAXANE AND AN ELEMENTARY KIT
CA2683712A1 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical compositions
RU2370258C2 (en) * 2007-11-16 2009-10-20 Закрытое Акционерное Общество "Биокад" Pharmaceutical composition for parenteral delivery in form of lyophilizate and method of its obtaining
CN110437179A (en) * 2019-08-22 2019-11-12 江苏红豆杉药业有限公司 A kind of taxol monocrystalline crystal and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (en) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa NEW PHARMACEUTICAL COMPOSITIONS BASED ON DERIVATIVES OF THE TAXANE CLASS.
RU2136673C1 (en) * 1992-12-24 1999-09-10 Бристоль-Мейерз Сквибб Компани Taxane derivative phosphonooxymethyl esters, intermediate compounds, antitumor pharmaceutical composition, method of tumor growth suppression in mammals
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates
FR2729666A1 (en) * 1995-01-25 1996-07-26 Rhone Poulenc Rorer Sa PROCESS FOR THE PREPARATION OF (2R, 3S) TRIHYDRATE - BENZOYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE OF 4,10-DIACETOXY- 2ALPHA-BENZOYLOXY-5BETA, 20-EPOXY-1,7BETA-DIHYDROXY-9-OX 11-EN-13ALPHA-YLE
FR2740686B1 (en) * 1995-11-03 1998-01-16 Sanofi Sa STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION

Also Published As

Publication number Publication date
CZ20031421A3 (en) 2004-06-16
SK287850B6 (en) 2012-01-04
LT5069B (en) 2003-11-25
SI21138A (en) 2003-08-31
DE60122384D1 (en) 2006-09-28
BG65985B1 (en) 2010-08-31
PL343615A1 (en) 2002-05-06
BG107764A (en) 2004-07-30
SI21138B (en) 2006-10-31
DE60122384T2 (en) 2007-08-16
LT2003031A (en) 2003-09-25
HK1060733A1 (en) 2004-08-20
ZA200303276B (en) 2004-04-21
CZ300836B6 (en) 2009-08-19
EP1363892A1 (en) 2003-11-26
WO2002036582A1 (en) 2002-05-10
HUP0303089A2 (en) 2003-12-29
UA75620C2 (en) 2006-05-15
HUP0303089A3 (en) 2005-02-28
PL203300B1 (en) 2009-09-30
EP1363892B1 (en) 2006-08-16
RU2236227C1 (en) 2004-09-20
SK6292003A3 (en) 2004-08-03

Similar Documents

Publication Publication Date Title
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
MXPA02003596A (en) Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation.
AU2331801A (en) Improved pharmaceutical compositions for poorly soluble drugs
IL149186A0 (en) Pharmaceutical compositions providing enhanced drug concentrations
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU4357800A (en) Intracellular pharmaceutical targeting
AU2002239397A1 (en) Drug formulation having improved oral tolerability
AU1724301A (en) Hydrogel-driven layered drug dosage form
AU2001234114A1 (en) Drugs containing combined active ingredients
AU2001270778A1 (en) Production, stabilisation and use of reduced forms of pharmaceutical compounds
AU2001238346A1 (en) Modification of biopolymers for improved drug delivery
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
AU7594900A (en) Pharmaceutical formulations containing poorly soluble drug substances
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU4977300A (en) Pharmaceutical formulations
AU2002212863A1 (en) Stable pharmaceutical form of an anticancer drug
AU2002350386A1 (en) Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AU1385801A (en) Pharmaceutical formulations
AU2002216864A1 (en) Conjugates of antibodies and anticancer drugs
AU2001295884A1 (en) Dispenser for endermic administration of drug
AU2001250625A1 (en) 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
EP1526838B8 (en) Intravenous pharmaceutical form of administration
AU6106801A (en) Trans-clitoral administration of therapy